HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 78 filers reported holding HARPOON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 5.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $152 | +4.1% | 213,600 | +8.7% | 0.00% | – |
Q1 2023 | $146 | -39.7% | 196,420 | -41.0% | 0.00% | – |
Q4 2022 | $242 | -99.9% | 332,974 | -30.8% | 0.00% | -100.0% |
Q3 2022 | $467,000 | -22.9% | 481,041 | +51.6% | 0.00% | 0.0% |
Q2 2022 | $606,000 | -42.3% | 317,361 | +50.3% | 0.00% | 0.0% |
Q1 2022 | $1,050,000 | +169.2% | 211,200 | +309.3% | 0.00% | – |
Q4 2021 | $390,000 | -87.7% | 51,600 | -87.1% | 0.00% | -100.0% |
Q3 2021 | $3,166,000 | +69.6% | 400,788 | +264.7% | 0.00% | +100.0% |
Q3 2020 | $1,867,000 | +2.2% | 109,900 | -0.1% | 0.00% | 0.0% |
Q2 2020 | $1,826,000 | +38.8% | 110,000 | -3.2% | 0.00% | +100.0% |
Q1 2020 | $1,316,000 | -20.5% | 113,603 | +1.5% | 0.00% | 0.0% |
Q4 2019 | $1,655,000 | +342.5% | 111,900 | +308.4% | 0.00% | – |
Q3 2019 | $374,000 | – | 27,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |